Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21301 AL 21315

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia

Szeto JY, Lewis SJ.

Curr Neuropharmacol. 2016;14(4):326-38. doi: 10.2174/1570159x14666151208112754.

Structural variants can be more informative for disease diagnostics, prognostics and translation than current SNP mapping and exon sequencing

Roses AD, Akkari PA, Chiba-Falek O, Lutz MW, Gottschalk WK, Saunders AM, Saul B, Sundseth S, Burns D.

Expert Opin Drug Metab Toxicol. 2016;12(2):135-47. doi: 10.1517/17425255.2016.1133586. Epub 2016 Feb 2.

Insights into Mechanisms of Chronic Neurodegeneration

Diack AB, Alibhai JD, Barron R, Bradford B, Piccardo P, Manson JC.

Int J Mol Sci. 2016 Jan 12;17(1):82. doi: 10.3390/ijms17010082.

Comorbidities Matter: A Call to Improve Care for Hospitalized Patients with Alzheimer's and Parkinson's Disease

DiBartolo MC.

J Gerontol Nurs. 2016 Feb;42(2):4-5. doi: 10.3928/00989134-20160113-01.

Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins

Butterfield DA, Palmieri EM, Castegna A.

Expert Rev Proteomics. 2016;13(3):259-74. doi: 10.1586/14789450.2016.1149470.

Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine

Nabavi SF, Braidy N, Habtemariam S, Sureda A, Manayi A, Nabavi SM.

Curr Top Med Chem. 2016;16(17):1910-5. doi: 10.2174/1568026616666160204121725.

Phage M13 for the treatment of Alzheimer and Parkinson disease

Messing J.

Gene. 2016 Jun 1;583(2):85-89. doi: 10.1016/j.gene.2016.02.005. Epub 2016 Feb 8.

Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases

Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA.

Drug Dev Res. 2016 May;77(3):109-23. doi: 10.1002/ddr.21294. Epub 2016 Feb 21.

Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure

Calderone A, Formenti M, Aprea F, Papa M, Alberghina L, Colangelo AM, Bertolazzi P.

BMC Syst Biol. 2016 Mar 2;10:25. doi: 10.1186/s12918-016-0270-7.

Retromer in Polarized Protein Transport

Vergés M.

Int Rev Cell Mol Biol. 2016;323:129-79. doi: 10.1016/bs.ircmb.2015.12.005. Epub 2016 Feb 3.

Glycation in Parkinson's disease and Alzheimer's disease

Vicente Miranda H, El-Agnaf OM, Outeiro TF.

Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.

Clinical drug research in chronic central neurodegenerative disorders

Müller T, Foley P.

Expert Rev Neurother. 2016 May;16(5):497-504. doi: 10.1586/14737175.2016.1163220. Epub 2016 Mar 21.

A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson's Disease, Alzheimer's Disease, Head Injury, and Pneumonia

Takizawa C, Gemmell E, Kenworthy J, Speyer R.

Dysphagia. 2016 Jun;31(3):434-41. doi: 10.1007/s00455-016-9695-9. Epub 2016 Mar 12.

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Salahuddin P, Fatima MT, Abdelhameed AS, Nusrat S, Khan RH.

Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias